Three of the greatest fears that a Sponsor experiences when initiating a new trial are: “What if the study does not enroll according to corporate timelines?”, “What if the study runs over budget?”, and “What if the data quality is subpar?” Each of these “what ifs” can have a significant cost implication for the Sponsor company, since a delay in timeline carries with it a delay in revenue actualization.


